1Cysteine-rich peptides (CRPs) of 2-6 kDa are generally thermally and proteolytically stable because of their multiple cross-bracing disulfide bonds. Here, we report the discovery and characterization of two novel cystine-stapled CRPs, designated lybatide 1 and 2 (lyba1 and lyba2), from the cortex of Lycium barbarum root. Lybatides, 32 to 33 amino acids in length, are hyperstable and display a novel disulfide connectivity with a cysteine motif of C-C-C-C-CC-CC which contains two pairs of adjacent cysteines (-CC-CC). X-ray structure analysis revealed the presence of a single cystine-stabilized (α + π)-helix in lyba2, a rare feature of CRPs. Together, our results suggest that lybatides, one of the smallest four-disulfideconstrained plant CRPs, is a new family of CRPs. Additionally, this study provides new insights into the molecular diversity of plant cysteine-rich peptides and the unusual lybatide scaffold could be developed as a useful template for peptide engineering and therapeutic development.Lycium barbarum, belonging to the Solanaceae family, is a deciduous shrub native to southeastern China 1 . It is the plant that produces the popular herb wolfberries or goji berries. However, the cortex of L. barbarum root ( or DiGuPi in Chinese) is also commonly used as a traditional Chinese medicine for treating chronic low-grade fever, cough, hemoptysis and hematuria, diabetes mellitus and hypertension 1 . A diverse group of secondary metabolites has been isolated from the cortex of L. barbarum root, including alkaloids, flavonoids and flavone glycosides. In addition, small cyclic peptides, namely licyumins A-D, with molecular weights <1 kDa, have been shown to inhibit renin and angiotensin-converting enzymes 2 . However, no bioactive peptides >2 kDa have been reported.Bioactive compounds from medicinal plants have been a source of inspiring structures for drug discovery. A majority of studies focuses on small molecules and secondary metabolites, with few studies focusing on peptides 3,4 . Even in studies relating to identifying peptides from plants, the focus is largely on small cyclic peptides. This bias is attributed to a general perception that peptides >2 kDa are unstable and readily denatured during a decoction preparation or in the gastrointestinal tract after ingestion. This is generally true for large peptides and proteins with molecular weight >8 kDa. However, cysteine-rich peptides (CRPs) with a molecular range of 2-6 kDa and 3-5 disulfide bonds are tolerant to thermal, chemical and proteolytic degradation 5 . As a group, CRPs in this defined chemical space have great potential as a source of leads and inspiration for developing useful drugs from medicinal plants 6,7 . Structurally, plant CRPs within the chemical space of 2-6 kDa can be arbitrarily classified into two major groups (Fig. 1). They are the cystine-stabilized α-helical (CSα) peptides and cystine-stabilized β-peptides. The CSα peptides can be found in plant CRPs >40 residues such as plant defensins and plant thionins. Cystine-stabilized β-peptid...